+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
AKUMS

Akums Drugs & Pharmaceuticals Share Price

₹686.60 +17.6 (2.63%)
67.75% Gain from 52W Low

26 Oct, 2026 3:50 PM (IST)

Akums Drugs & Pharmaceuticals live price: ₹686.60. It opened at ₹665 vs previous close ₹669; intraday high/low: ₹689/₹658. The 50 & 200 DMA stand at ₹744.60/₹641.50.

Akums Drugs & Pharmaceuticals Performance

  • Today's Low
  • ₹658
  • Today's High
  • ₹689
  • 52 Week Low
  • ₹409
  • 52 Week High
  • ₹839
  • Open Price₹665
  • Previous Close₹669
  • Volume152,899
  • 50 DMA₹744.60
  • 100 DMA₹703.40
  • 200 DMA₹641.50

Akums Drugs & Pharmaceuticals Chart

Investment Returns

  • Over 1 Month -16.22%
  • Over 3 Month -0.1%
  • Over 6 Month + 33.5%
  • Over 1 Year + 49.08%

Smart Investing Starts Here Start SIP with Akums Drugs & Pharmaceuticals for Steady Growth!

Invest Now

Akums Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 37
  • PEG Ratio
  • -2.5
  • Market Cap Cr
  • 10,807
  • P/B Ratio
  • 3.2
  • Average True Range
  • 28.6
  • EPS
  • 18.5
  • Dividend Yield
  • 0.4
  • MACD Signal
  • -24.7
  • RSI
  • 33.77
  • MFI
  • 22.1

Latest Stock News Updates

Akums Drugs and Pharmaceuticals Ltd - 544222 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Demand Notice

Demand Notice - National Pharmaceuticals Pricing Authority

Akums Drugs and Pharmaceuticals Ltd - 544222 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018

Akums Drugs and Pharmaceuticals Ltd - 544222 - Closure of Trading Window

Closure of Trading Window

Akums Drugs & Pharmaceuticals Financials

Akums Drugs & Pharmaceuticals Technicals

EMA & SMA

Current Price
₹686.60
+ 17.6 (2.63%)
pointer
  • Bearish Moving Average 13
  • Bullish Moving Average 3
  • 20 Day
  • ₹741.40
  • 50 Day
  • ₹744.60
  • 100 Day
  • ₹703.40
  • 200 Day
  • ₹641.50

Resistance and Support

677.73 Pivot Speed
  • R3 728.00
  • R2 708.30
  • R1 697.40
  • S1 666.90
  • S2 647.20
  • S3 636.30

Akums Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-08 Quarterly Results
2026-05-14 Audited Results & Final Dividend
2026-02-13 Quarterly Results
2025-11-13 Quarterly Results
2025-08-08 Quarterly Results
Date Purpose Remarks
2026-07-03 FINAL Rs.1.00 per share(50%)Final Dividend
2026-07-03 SPECIAL Rs.2.00 per share(100%)Special Dividend
View Akums Drugs & Pharmaceuticals Dividend History Arrow

Akums Drugs & Pharmaceuticals Shareholding Pattern

75.26%
7.58%
6.42%
4.5%
3.51%

About Akums Drugs & Pharmaceuticals

Akums Drugs & Pharmaceuticals is engaged in contract manufacturing which involves manufacturing of pharmaceutical formulations and specializes in developing new formulations, undertaking bio equivalence studies, clinical trials, obtaining Drug Controller General of India's (DCGI) approval for manufacturing and marketing new Fixed Dose Combinations (FDCs) & molecules and thereby offering new formulations with Company's own technology to its customers under their brand names.(Source : AR-PDF:202603-01 Pg No:223) View More
  • NSE Symbol
  • AKUMS
  • BSE Symbol
  • 544222
  • ISIN
  • INE09XN01023

Similar Stocks to Akums Drugs & Pharmaceuticals

Akums Drugs & Pharmaceuticals FAQs

Akums Drugs & Pharmaceuticals share price is ₹686 As on 26 October, 2026 | 23:15

The Market Cap of Akums Drugs & Pharmaceuticals is ₹10806.7 Cr As on 26 October, 2026 | 23:15

The P/E ratio of Akums Drugs & Pharmaceuticals is 37 As on 26 October, 2026 | 23:15

The PB ratio of Akums Drugs & Pharmaceuticals is 3.2 As on 26 October, 2026 | 23:15

The 52 week High & Low of Akums Drugs & Pharmaceuticals is ₹838.8/₹409.3 respectively As on 26 October, 2026 | 23:15

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23